News
During the quarter, Voya Global Equity Dividend And Premium Opportunity Fund underperformed its Index largely due to beta ...
For 2Q, Macquarie Diversified Income Fund Institutional Class shares outperformed the Fund’s benchmark, the Bloomberg US ...
Revenue -- Revenue (GAAP) totaled approximately $1.25 million for the six months ended June 30, 2025, down from $1.75 million ...
Tencent reported second-quarter revenue growth of 15% on Wednesday, driven by robust gaming performance and deployment of AI ...
Tencent reported second-quarter revenue growth of 15% on Wednesday, driven by robust gaming performance and AI-powered ...
Strong Results Reflect Rising Demand, Business Growth, and Strategic Investments Amid Saudi Arabia’s Accelerating Energy ...
Chief Financial Officer Barry Berlin reported, "Our FFO was negative $7.9 million or negative $10.42 per diluted share compared to negative $3.3 million or negative $3.46 per diluted share in the ...
Revenue -- $4.5 million in revenue for fiscal Q2 2025 (period ended June 30, 2025), a decrease of $900,000 compared to fiscal Q2 2024, primarily due to discontinued contracts in premium and proactive ...
License fee revenue increased 4% in Q2 2025, supported by a growing subscription contract base. Service Revenue-- Service revenue rose 11% in Q2 2025, mostly due to customer service activities for a ...
NuScale Power Q2 revenues surge 733% on SMR advances and new NRC approval, but steep valuation and tough competition warrant a cautious approach for the stock.
CoreWeave reported strong Q2 revenue, but profitability lagged and shares fell in after hours trading amid rising costs and ...
Cytokinetics Incorporated (NASDAQ:CYTK) is one of the best upside stocks to invest in now. On August 8, Citi lowered the firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results